We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 208 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 208 → 0 (-208)

100% less funds holding in top 10

Funds holding in top 10: 10 → 0 (-10)

100% less capital invested

Capital invested by funds: $3.06B → $0 (-$3.06B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 208

Holders
–
Holders Change
-208
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
208
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$313M
2
BlackRock
BlackRock
New York
-$285M
3
CAM
Cormorant Asset Management
Massachusetts
-$187M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$144M
5
State Street
State Street
Massachusetts
-$124M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
176
Simplex Trading
Illinois
– -$136K -1,818 Closed
FIA
177
FNY Investment Advisers
New York
– -$130K -1,730 Closed
US Bancorp
178
US Bancorp
Minnesota
– -$124K -1,648 Closed
Allspring Global Investments
179
Allspring Global Investments
North Carolina
– -$122K -1,628 Closed
CG
180
Cutler Group
California
– -$90K -1,200 Closed
SC
181
Shay Capital
New York
– -$90K -1,200 Closed
Macquarie Group
182
Macquarie Group
Australia
– -$90K -1,193 Closed
HWM
183
HighMark Wealth Management
Minnesota
– -$67K -895 Closed
PHK
184
Point72 Hong Kong
Hong Kong
– -$59K -781 Closed
Walleye Trading
185
Walleye Trading
New York
– -$41K -544 Closed
Osaic Holdings
186
Osaic Holdings
Arizona
– -$34K -447 Closed
Royal Bank of Canada
187
Royal Bank of Canada
Ontario, Canada
– -$27K -361 Closed
NICM
188
Neo Ivy Capital Management
New York
– -$19K -257 Closed
CAPTRUST Financial Advisors
189
CAPTRUST Financial Advisors
North Carolina
– -$15K -195 Closed
TWA
190
TCI Wealth Advisors
Arizona
– -$15K -194 Closed
Daiwa Securities Group
191
Daiwa Securities Group
Japan
– -$14K -185 Closed
IUHSA
192
Itau Unibanco Holding S.A.
Brazil
– -$10K -139 Closed
S
193
SignatureFD
Georgia
– -$9K -123 Closed
PNC Financial Services Group
194
PNC Financial Services Group
Pennsylvania
– -$7K -97 Closed
LC
195
Lindbrook Capital
California
– -$6K -80 Closed
EW
196
Evoke Wealth
California
– -$6K -75 Closed
BIA
197
Bell Investment Advisors
California
– -$3K -36 Closed
EI
198
Ellevest Inc
New York
– -$2K -25 Closed
QCG
199
Quadrant Capital Group
Ohio
– -$2K -24 Closed
GWS
200
Glassman Wealth Services
Virginia
– -$2K -20 Closed
5 6 7
8
9

TPTX Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q3 2022, worth a combined $0 — down 100% from $3.06B a quarter earlier.

Sellers outnumbered buyers: 208 funds closed out of TPTX and 0 opened new positions — a net loss of 208 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $313M sold.

  • 0 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q3 2022, down from 208 in Q2 2022.
  • Funds reported $0 of Turning Point Therapeutics, Inc. Common Stock stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q3 2022 and 208 closed out, a net change of -208 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $313M sold.

Based on aggregated 13F filings for Q3 2022.